134 related articles for article (PubMed ID: 15052723)
1. [Final verification of the preoperatively diagnosed "ovarian tumor" with the clinical characteristic of patients].
Bieńkiewicz A; Gottwald L; Giernat L; Suzin J
Przegl Lek; 2003; 60(10):637-9. PubMed ID: 15052723
[TBL] [Abstract][Full Text] [Related]
2. Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics.
Antila R; Jalkanen J; Heikinheimo O
Gynecol Oncol; 2006 Apr; 101(1):97-101. PubMed ID: 16278010
[TBL] [Abstract][Full Text] [Related]
3. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
4. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
Skírnisdóttir I; Garmo H; Holmberg L
Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
[TBL] [Abstract][Full Text] [Related]
5. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
Wingo SN; Knowles LM; Carrick KS; Miller DS; Schorge JO
Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
[TBL] [Abstract][Full Text] [Related]
6. Surgical staging of ovarian low malignant potential tumors.
Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
8. Role of laparoscopy in the diagnosis and treatment of adnexal masses.
Leng JH; Lang JH; Zhang JJ; Feng FZ; Liu ZF; Sun DW; Zhu L; Zhao XY
Chin Med J (Engl); 2006 Feb; 119(3):202-6. PubMed ID: 16537005
[TBL] [Abstract][Full Text] [Related]
9. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
11. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.
Ramirez PT; Slomovitz BM; McQuinn L; Levenback C; Coleman RL
Gynecol Oncol; 2006 Dec; 103(3):888-90. PubMed ID: 16806436
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
13. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
[TBL] [Abstract][Full Text] [Related]
14. [Borderline ovarian tumors: an update].
Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
[TBL] [Abstract][Full Text] [Related]
15. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
16. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
[TBL] [Abstract][Full Text] [Related]
17. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
18. Are borderline tumors of the ovary safely treated by laparoscopy?
Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
[TBL] [Abstract][Full Text] [Related]
19. [Clinical-morphological parallels of malignant ovarian tumours].
Zurabiani TA; Charkviani LI; Gersamiia GK; Charkviani TL
Georgian Med News; 2006 Oct; (139):70-3. PubMed ID: 17077473
[TBL] [Abstract][Full Text] [Related]
20. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
Kumpulainen S; Kuoppala T; Leminen A; Komulainen M; Puistola U; Sankila R; Mäkinen J; Grénman S
Acta Obstet Gynecol Scand; 2007; 86(5):610-4. PubMed ID: 17464592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
